RMD Stock - ResMed Inc.
Unlock GoAI Insights for RMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.15B | $4.69B | $4.22B | $3.58B | $3.20B |
| Gross Profit | $3.05B | $2.66B | $2.36B | $2.02B | $1.84B |
| Gross Margin | 59.4% | 56.7% | 55.8% | 56.6% | 57.5% |
| Operating Income | $1.69B | $1.32B | $1.13B | $1.00B | $903.68M |
| Net Income | $1.40B | $1.02B | $897.56M | $779.44M | $474.50M |
| Net Margin | 27.2% | 21.8% | 21.3% | 21.8% | 14.8% |
| EPS | $9.55 | $6.94 | $6.12 | $5.34 | $3.27 |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 16th 2025 | Robert W. Baird | Downgrade | Neutral | $275 |
| September 18th 2025 | Citigroup | Initiation | Buy | $330 |
| September 2nd 2025 | CLSA | Upgrade | Outperform | - |
| July 15th 2025 | RBC Capital Mkts | Upgrade | Outperform | $294 |
| March 19th 2025 | Morgan Stanley | Initiation | Overweight | - |
| January 16th 2025 | Goldman | Initiation | Buy | - |
| January 10th 2025 | Piper Sandler | Initiation | Neutral | $252 |
| December 13th 2024 | Stifel | Initiation | Hold | $250 |
| September 24th 2024 | Robert W. Baird | Initiation | Outperform | $280 |
| September 18th 2024 | Wolfe Research | Downgrade | Underperform | $180 |
| September 4th 2024 | Needham | Downgrade | Hold | - |
| June 25th 2024 | Oppenheimer | Downgrade | Perform | - |
| June 24th 2024 | Citigroup | Downgrade | Neutral | - |
| February 6th 2024 | KeyBanc Capital Markets | Resumed | Overweight | $227 |
| October 27th 2023 | Morgan Stanley | Upgrade | Overweight | $169← $180 |
Earnings History & Surprises
RMDEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 21, 2026 | — | — | — | — |
Q1 2026 | Jan 29, 2026 | $2.68 | — | — | — |
Q4 2025 | Oct 30, 2025 | $2.51 | $2.55 | +1.6% | ✓ BEAT |
Q3 2025 | Jul 31, 2025 | $2.55 | $2.55 | 0.0% | = MET |
Q2 2025 | Apr 23, 2025 | $2.38 | $2.37 | -0.4% | ✗ MISS |
Q1 2025 | Jan 30, 2025 | $2.32 | $2.43 | +4.7% | ✓ BEAT |
Q4 2024 | Oct 24, 2024 | $2.04 | $2.20 | +7.8% | ✓ BEAT |
Q3 2024 | Aug 1, 2024 | $2.07 | $2.08 | +0.5% | ✓ BEAT |
Q2 2024 | Apr 25, 2024 | $1.91 | $2.13 | +11.5% | ✓ BEAT |
Q1 2024 | Jan 24, 2024 | $1.81 | $1.88 | +3.9% | ✓ BEAT |
Q4 2023 | Oct 26, 2023 | $1.62 | $1.64 | +1.2% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $1.69 | $1.60 | -5.3% | ✗ MISS |
Q2 2023 | Apr 27, 2023 | $1.59 | $1.68 | +5.7% | ✓ BEAT |
Q1 2023 | Jan 26, 2023 | $1.62 | $1.66 | +2.5% | ✓ BEAT |
Q4 2022 | Oct 27, 2022 | $1.52 | $1.51 | -0.7% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | $1.45 | $1.49 | +2.8% | ✓ BEAT |
Q2 2022 | Apr 28, 2022 | $1.42 | $1.32 | -7.0% | ✗ MISS |
Q1 2022 | Jan 27, 2022 | $1.52 | $1.47 | -3.3% | ✗ MISS |
Q4 2021 | Oct 28, 2021 | $1.36 | $1.51 | +11.0% | ✓ BEAT |
Q3 2021 | Aug 5, 2021 | $1.30 | $1.35 | +3.8% | ✓ BEAT |
Latest News
Stifel Maintains Hold on ResMed, Lowers Price Target to $260
➖ NeutralBaird Downgrades ResMed to Neutral, Lowers Price Target to $275
📉 NegativeResmed Receives FDA Clearance For Personalized Therapy Comfort Settings, To Ve Marketed As Smart Comfort,To Help Personalize CPAP Therapy
📈 PositiveBaird Maintains Outperform on ResMed, Lowers Price Target to $300
➖ NeutralRBC Capital Maintains Outperform on ResMed, Raises Price Target to $303
📈 PositiveKeybanc Maintains Overweight on ResMed, Raises Price Target to $299
📈 PositiveMizuho Maintains Outperform on ResMed, Lowers Price Target to $300
📈 PositiveResMed Q1 Adj. EPS $2.55 Beats $2.50 Estimate, Sales $1.336B Beat $1.331B Estimate
📈 PositiveMorgan Stanley Maintains Overweight on ResMed, Raises Price Target to $304
📈 PositiveCitigroup Initiates Coverage On ResMed with Buy Rating, Announces Price Target of $330
📈 PositiveFrequently Asked Questions about RMD
What is RMD's current stock price?
What is the analyst price target for RMD?
What sector is ResMed Inc. in?
What is RMD's market cap?
Does RMD pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to RMD for comparison